The institutional landscape for Pliant Therapeutics, Inc. (NASDAQ:PLRX) includes 94 filers as of the latest reporting cycle ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 6,143,132 | 139,686 | 2.33% | $7,494,621.00 |
| Blue Owl Capital Holdings LP | 31 Dec, 2025 | 2,969,199 | 0 | 0.00% | $3,622,423.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 2,818,241 | 42,303 | 1.52% | $3,438,255.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 2,583,332 | 243,864 | 10.42% | $3,151,665.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Dec, 2025 | 2,364,669 | -4,873 | -0.21% | $2,879.00 |
| Woodline Partners LP | 31 Dec, 2025 | 2,026,191 | -2,478,626 | -55.02% | $2,471,953.00 |
| Monaco Asset Management SAM | 31 Dec, 2025 | 1,938,747 | 1,116,054 | 135.66% | $2,365,271.00 |
| Redmile Group, LLC | 31 Dec, 2025 | 1,616,228 | 24,533 | 1.54% | $1,971,798.00 |
| Prosight Management, LP | 31 Dec, 2025 | 1,555,744 | 1,535,257 | 7,493.81% | $1,898,008.00 |
| BML Capital Management, LLC | 31 Dec, 2025 | 1,546,137 | 1,546,137 | 0.00% | $1,886,287.00 |
| TWO SIGMA ADVISERS, LP | 31 Dec, 2025 | 1,245,600 | 173,100 | 16.14% | $1,519,632.00 |
| JPMORGAN CHASE & CO | 31 Dec, 2025 | 1,212,875 | -917,614 | -43.07% | $1,479,707.00 |
| MARSHALL WACE, LLP | 31 Dec, 2025 | 1,080,128 | 780,667 | 260.69% | $1,317,756.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 1,073,272 | -347,591 | -24.46% | $1,309,392.00 |
| UBS Group AG | 31 Dec, 2025 | 1,062,615 | -259,402 | -19.62% | $1,296,390.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 1,045,818 | 34,016 | 3.36% | $1,275,898.00 |
| Centiva Capital, LP | 31 Dec, 2025 | 1,000,000 | 1,000,000 | 0.00% | $1,220,000.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 953,293 | 170,038 | 21.71% | $1,163,017.00 |
| Peapod Lane Capital LLC | 31 Dec, 2025 | 886,374 | -210,654 | -19.20% | $1,081,376.00 |
| Eversept Partners, LP | 31 Dec, 2025 | 842,023 | 17,429 | 2.11% | $1,027,268.00 |